New Approach Methodology for Assessing Inhalation Risks of a Contact Respiratory Cytotoxicant: Computational Fluid Dynamics-Based Aerosol Dosimetry Modeling for Cross-Species and In Vitro Comparisons.


Journal

Toxicological sciences : an official journal of the Society of Toxicology
ISSN: 1096-0929
Titre abrégé: Toxicol Sci
Pays: United States
ID NLM: 9805461

Informations de publication

Date de publication:
03 08 2021
Historique:
pubmed: 3 6 2021
medline: 19 8 2021
entrez: 2 6 2021
Statut: ppublish

Résumé

Regulatory agencies are considering alternative approaches to assessing inhalation toxicity that utilizes in vitro studies with human cells and in silico modeling in lieu of additional animal studies. In support of this goal, computational fluid-particle dynamics models were developed to estimate site-specific deposition of inhaled aerosols containing the fungicide, chlorothalonil, in the rat and human for comparisons to prior rat inhalation studies and new human in vitro studies. Under bioassay conditions, the deposition was predicted to be greatest at the front of the rat nose followed by the anterior transitional epithelium and larynx corresponding to regions most sensitive to local contact irritation and cytotoxicity. For humans, simulations of aerosol deposition covering potential occupational or residential exposures (1-50 µm diameter) were conducted using nasal and oral breathing. Aerosols in the 1-5 µm range readily penetrated the deep region of the human lung following both oral and nasal breathing. Under actual use conditions (aerosol formulations >10 µm), the majority of deposited doses were in the upper conducting airways. Beyond the nose or mouth, the greatest deposition in the pharynx, larynx, trachea, and bronchi was predicted for aerosols in the 10-20 µm size range. Only small amounts of aerosols >20 µm penetrated past the pharyngeal region. Using the ICRP clearance model, local retained tissue dose metrics including maximal concentrations and areas under the curve were calculated for each airway region following repeated occupational exposures. These results are directly comparable with benchmark doses from in vitro toxicity studies in human cells leading to estimated human equivalent concentrations that reduce the reliance on animals for risk assessments.

Identifiants

pubmed: 34077545
pii: 6291255
doi: 10.1093/toxsci/kfab062
pmc: PMC8331159
doi:

Substances chimiques

Aerosols 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-259

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL073598
Pays : United States
Organisme : NIH HHS
ID : R01 HL073598
Pays : United States
Organisme : National Heart, Lung and Blood Institute
Organisme : Battelle Memorial Institute
ID : TK0253671
Organisme : NIEHS NIH HHS
ID : U01 ES028669
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Society of Toxicology.

Références

J Agric Saf Health. 2019 Apr 16;25(2):91-103
pubmed: 32429610
Ann ICRP. 2015 Sep;44(2):5-188
pubmed: 26494836
Inhal Toxicol. 2014 Aug;26(9):524-44
pubmed: 25055841
Aerosol Sci Technol. 2018;52(5):483-493
pubmed: 30381781
Toxicol Sci. 2014 Apr;138(2):412-24
pubmed: 24385418
Inhal Toxicol. 2009 Jun;21(7):607-18
pubmed: 19459775
Br J Ind Med. 1980 Nov;37(4):337-62
pubmed: 7004477
Regul Toxicol Pharmacol. 1996 Aug;24(1 Pt 1):69-84
pubmed: 8921547
J Aerosol Sci. 2021 Jan;151:
pubmed: 34024935
Inhal Toxicol. 2008 Oct;20(13):1179-89
pubmed: 18802802
Proc Inst Mech Eng H. 2017 May;231(5):355-368
pubmed: 28427314
J Occup Environ Hyg. 2015;12 Suppl 1:S18-40
pubmed: 26551218
Inhal Toxicol. 2010 Mar;22(4):287-300
pubmed: 20070173
Ann Occup Hyg. 1995 Jun;39(3):317-28
pubmed: 7793751
Comput Biol Med. 2016 Dec 1;79:193-204
pubmed: 27810625
Toxicol Sci. 2012 Aug;128(2):500-16
pubmed: 22584687
Toxicol Sci. 2006 Mar;90(1):198-207
pubmed: 16344266
J Biomech. 2010 Aug 10;43(11):2159-63
pubmed: 20483412
Pharm Res. 2012 Jun;29(6):1670-88
pubmed: 22290350
Fundam Appl Toxicol. 1995 Nov;28(1):41-50
pubmed: 8566482
J Aerosol Med Pulm Drug Deliv. 2016 Dec;29(6):461-481
pubmed: 27082824
Inhal Toxicol. 2012 Jan;24(1):27-35
pubmed: 22145784
J Aerosol Sci. 2016 Sep;99:64-77
pubmed: 33311732
Toxicol Sci. 2001 Dec;64(2):253-8
pubmed: 11719708
J Comput Phys. 2013 Jul 1;244:168-192
pubmed: 23794749
Environ Res. 2008 Nov;108(3):400-3
pubmed: 18801479
Environ Health Perspect. 1984 Apr;55:369-90
pubmed: 6376108
Toxicol Sci. 2015 Jul;146(1):65-88
pubmed: 25858911
J Toxicol Environ Health. 1984;13(2-3):441-69
pubmed: 6376822
Inhal Toxicol. 2005 Dec 15;17(14):823-30
pubmed: 16282160
Ann ICRP. 1994;24(1-3):1-482
pubmed: 7726471
Inhal Toxicol. 2008 Sep;20(12):1093-100
pubmed: 18800272
Toxicol Sci. 2001 Nov;64(1):100-10
pubmed: 11606806
J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):153-66
pubmed: 26270330
Inhal Toxicol. 2008 Feb;20(3):227-43
pubmed: 18300045

Auteurs

Richard A Corley (RA)

Pacific Northwest National Laboratory, Richland, Washington 99352, USA.

Andrew P Kuprat (AP)

Pacific Northwest National Laboratory, Richland, Washington 99352, USA.

Sarah R Suffield (SR)

Pacific Northwest National Laboratory, Richland, Washington 99352, USA.

Senthil Kabilan (S)

Pacific Northwest National Laboratory, Richland, Washington 99352, USA.

Paul M Hinderliter (PM)

Syngenta Crop Protection, Greensboro, North Carolina 27409, USA.

Kevin Yugulis (K)

Battelle Memorial Institute, Columbus, Ohio 43201, USA.

Tharacad S Ramanarayanan (TS)

Syngenta Crop Protection, Greensboro, North Carolina 27409, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH